home / stock / cvrx / cvrx news

CVRX News and Press, CVRx Inc.

Stock Information
Company Name: CVRx Inc.
Stock Symbol: CVRX
Market: NASDAQ
Website: cvrx.com
Menu
CVRX CVRX Quote CVRX Short CVRX News CVRX Articles CVRX Message Board
Get CVRX Alerts

News, Short Squeeze, Breakout and More Instantly...
CVRX - CVRX Price Target Alert: $10.00. Issued by Canaccord Genuity

2026-02-13 07:04:21 ET William Plovanic from Canaccord Genuity issued a price target of $10.00 for CVRX on 2026-02-13 11:53:12. The adjusted price target was set to $10.00. At the time of the announcement, CVRX was trading at $5.69. The overall price target consensus is ...
CVRX - CVRx outlines $63M-$67M 2026 revenue target as Barostim adoption accelerates with new CPT code

2026-02-12 22:15:11 ET More on CVRx CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

CVRX - CVRx, Inc. (CVRX) Q4 2025 Earnings Call Transcript

2026-02-12 22:14:20 ET CVRx, Inc. (CVRX) Q4 2025 Earnings Call February 12, 2026 4:30 PM EST Company Participants Kevin Hykes - President, CEO & Director Jared Oasheim - Chief Financial Officer Conference Call Participants Michael Vallie John ...

CVRX - CVRx GAAP EPS of -$0.46 misses by $0.02, revenue of $16M beats by $0.17M

2026-02-12 16:24:58 ET More on CVRx CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript CVRx reports preliminary 2025 results, issues 2026 guida...
CVRX - CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

MINNEAPOLIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and o...

CVRX - Expected US Company Earnings on Thursday, February 12th, 2026

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...

CVRX - Quant snapshot: Manulife, KBC, Ambev lead strong buys as Ultragenyx, Atomera lag

2026-02-08 13:40:45 ET More on U.S. Markets 96 of 123 S&P 500 companies post EPS growth in latest earnings week: Earnings scorecard Liquidity Drain And Event Risk May Cre ate A Volatile Week For Markets Dow Powers Past 50,000 - Momentum Or Market Euphoria? ...
CVRX - CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to re...

CVRX - CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced initiation of the BENEFIT-HF clinical trial, ...

CVRX - CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 21:15:57 ET CVRx, Inc. (CVRX) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:45 PM EST... Read the full article on Seeking Alpha For further details see: CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Next 10